Cinctive Capital Management LP Nurix Therapeutics, Inc. Transaction History
Cinctive Capital Management LP
- $1.23 Billion
- Q1 2025
A detailed history of Cinctive Capital Management LP transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 38,770 shares of NRIX stock, worth $446,630. This represents 0.04% of its overall portfolio holdings.
Number of Shares
38,770
Previous 158,972
75.61%
Holding current value
$446,630
Previous $3 Million
84.64%
% of portfolio
0.04%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding NRIX
# of Institutions
181Shares Held
74.4MCall Options Held
56.9KPut Options Held
7.9K-
Black Rock Inc. New York, NY6.82MShares$78.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.5MShares$63.4 Million2.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$50.9 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.05MShares$46.7 Million5.06% of portfolio
-
Commodore Capital LP New York, NY3.98MShares$45.8 Million4.63% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $543M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...